Analgesics and Anti-inflammatory Drugs Practice Questions

Q: Most important side effect of aspirin is?

Gastritis. ***Gastritis (and GI toxicity)*** - Aspirin, a **nonsteroidal anti-inflammatory drug (NSAID)**, inhibits **cyclooxygenase (COX) enzymes**, which reduces prostaglandin synthesis [2]. - Reduced prostaglandins in the stomach decrease **mucus production** and **bicarbonate secretion**, leading to mucosal damage and an increased risk of **gastritis, peptic ulcers, and gastrointestinal bleeding** [1]. - This is the **most common and clinically significant** adverse effect of aspirin, occurring in a dose-dependent manner and being the primary reason for discontinuation or requiring gastroprotective co-therapy. *Edema* - While some NSAIDs can cause **fluid retention** and edema by affecting renal function, this is not the most significant or common side effect of aspirin compared to its gastrointestinal effects [2]. - Edema is more prominent with other NSAIDs that have a stronger effect on **renal prostaglandin inhibition**. *Kidney damage* - **Aspirin can be nephrotoxic**, especially in high doses or with prolonged use, by inhibiting renal prostaglandins that regulate blood flow and glomerular filtration [1]. - However, **gastritis and GI bleeding** are generally considered more frequent and severe primary side effects in clinical practice. *Hypersensitivity* - **Aspirin-induced asthma** and other hypersensitivity reactions (like urticaria or angioedema) can occur, especially in individuals with pre-existing asthma or nasal polyps [1]. - While clinically significant, **gastric irritation and bleeding** are more common and are dose-dependent side effects directly related to its mechanism of action.

Q: Which of the following is an opioid agonist-antagonist?

Pentazocine. ***Pentazocine*** - Pentazocine is a **mixed opioid agonist-antagonist**, acting as an agonist at the kappa (κ) opioid receptor and an antagonist or partial agonist at the mu (μ) opioid receptor. - This dual action makes it a **partial analgesic**, but it can also precipitate withdrawal in opioid-dependent individuals. *Pethidine* - Pethidine (meperidine) is a **pure opioid agonist**, primarily acting at the mu (μ) opioid receptor. - It is used for **moderate to severe pain** but is associated with the accumulation of a toxic metabolite, normeperidine, which can cause seizures. *Buprenorphine* - Buprenorphine is a **partial mu (μ) opioid agonist** and a kappa (κ) opioid receptor antagonist. - While it has mixed properties, it is specifically described as a **partial agonist** for its primary analgesic effect, not a typical agonist-antagonist in the same class as pentazocine. *Methadone* - Methadone is a **full opioid agonist** at the mu (μ) opioid receptor, with additional NMDA receptor antagonism and norepinephrine and serotonin reuptake inhibition. - It is known for its **long duration of action** and is primarily used in opioid dependence treatment and chronic pain management.

Q: Which drug has a ceiling effect?

Buprenorphine. ***Buprenorphine*** - Buprenorphine is a **partial opioid agonist**, meaning that it still activates opioid receptors but with a **maximum effect** that is lower than that of full opioid agonists. - Due to its partial agonism, increasing the dose beyond a certain point does not result in a proportional increase in analgesic effect or respiratory depression, demonstrating a **ceiling effect**. *Morphine* - Morphine is a **full opioid agonist** that does not have a ceiling effect for analgesia or respiratory depression. - Its effects continue to increase with increasing doses until severe adverse effects like **respiratory depression** become prohibitive. *Pethidine* - Pethidine (meperidine) is a **full opioid agonist** with no ceiling effect for analgesia or respiratory depression. - Increasing the dose leads to further analgesic effects and an increased risk of **neurotoxicity** due to its metabolite, **normeperidine**. *Fentanyl* - Fentanyl is a potent **full opioid agonist** that also lacks a ceiling effect. - Higher doses rapidly produce greater analgesia and can cause severe, dose-dependent **respiratory depression**.

Q: Belimumab is used in

Systemic lupus erythematosus. ***Systemic lupus erythematosus*** - **Belimumab** is a monoclonal antibody that targets and inhibits **B-cell activating factor (BAFF)**, reducing the survival of autoreactive B cells. - This medication is FDA-approved for the treatment of **active systemic lupus erythematosus (SLE)** in patients who are receiving standard therapy. *Osteoporosis* - **Osteoporosis** is primarily treated with bisphosphonates, denosumab, teriparatide, or romosozumab, which focus on bone density and remodeling. - Belimumab has **no direct mechanism of action** for increasing bone mass or preventing bone resorption. *Malignant melanoma* - **Malignant melanoma** is typically treated with surgical excision, targeted therapies (e.g., BRAF/MEK inhibitors), or immunotherapies (e.g., PD-1 or CTLA-4 inhibitors). - Belimumab's mechanism of action, targeting B-cell activating factor, is **not relevant to the treatment of melanoma**. *Merkel cell carcinoma* - **Merkel cell carcinoma** is a rare and aggressive skin cancer primarily treated with surgery, radiation, and immunotherapy, particularly PD-1 inhibitors like avelumab. - Belimumab's role in modulating B-cell activity **does not apply to the pathogenesis or treatment of Merkel cell carcinoma**.

Q: Azathioprine is used as a treatment for which specific condition?

Autoimmune diseases. ***Autoimmune diseases*** - **Azathioprine** is a **purine analogue** that acts as an **immunosuppressant**, making it effective in managing various autoimmune conditions by reducing the immune response. - It is specifically used in diseases like **rheumatoid arthritis** [1], lupus, Crohn's disease, and in **organ transplantation** to prevent rejection [1]. *Gout* - **Gout** is an inflammatory arthritis caused by the deposition of **urate crystals** in the joints. - Treatment typically involves **NSAIDs**, **colchicine**, and **allopurinol** (to lower uric acid), not immunosuppressants like azathioprine. *HIV infection* - **HIV infection** is a viral disease that attacks the immune system, requiring **antiretroviral therapy (ART)** to control viral replication. - Azathioprine is not used for HIV treatment as it would further suppress an already compromised immune system. *Cancer* - While some **cytotoxic agents** are used in cancer therapy, azathioprine is primarily an immunosuppressant and its role in cancer treatment is limited. - **Chemotherapy** for cancer involves agents specifically designed to target and kill rapidly dividing cancer cells through various mechanisms.

Q: Which among the following drugs produces a dose ceiling effect?

Buprenorphine (partial agonist). ***Buprenorphine*** - **Buprenorphine** is a **partial opioid agonist**, meaning its effects, particularly respiratory depression, plateau at higher doses. - This **ceiling effect** means that increasing the dose beyond a certain point does not produce additional analgesic or respiratory depressant effects, making it safer in terms of overdose risk. *Alfentanil (short-acting opioid)* - **Alfentanil** is a **full opioid agonist** that does not exhibit a dose ceiling effect; its effects, including respiratory depression, continue to increase with higher doses. - It is known for its **rapid onset and short duration of action**, making it suitable for brief procedural sedation. *Remifentanil (ultra-short-acting opioid)* - **Remifentanil** is an **ultra-short-acting full opioid agonist** with no dose ceiling effect, meaning its pharmacological effects escalate with increasing doses. - Its unique **esterase metabolism** allows for very rapid offset, making it ideal for maintaining precise anesthetic depth. *Morphine (full agonist)* - **Morphine** is a **full opioid agonist** that does not have a dose ceiling effect; its analgesic and respiratory depressant effects continue to increase as the dose is raised. - It is a **prototypical opioid** often used for moderate to severe pain and is associated with significant dose-dependent side effects.

Q: Aspirin is used in chemoprevention of which cancer?

Colon cancer. ***Colon cancer*** - Aspirin has shown a role in **chemoprevention** for colorectal cancer, particularly in individuals with a high risk or a history of adenomas. - Its anti-inflammatory properties, specifically through **COX inhibition**, are thought to reduce tumor growth and metastasis in the colon. *Pancreatic cancer* - While some studies have explored aspirin's potential role, there is currently **insufficient evidence** to recommend it for the prevention or treatment of pancreatic cancer. - Pancreatic cancer is often diagnosed at advanced stages, and aspirin's benefits are primarily in **early prevention**. *Liver cancer* - Current research is **exploratory** regarding aspirin's role in liver cancer, primarily in **hepatocellular carcinoma (HCC)** patients. - Its use is not a standard recommendation for the management or prevention of liver cancer. *Stomach cancer* - There is **mixed and inconclusive evidence** regarding aspirin's direct benefit in stomach cancer prevention or treatment. - The primary concern with regular aspirin use in gastric conditions is the increased risk of **gastrointestinal bleeding** and ulcers.

Q: Which among the following is a mechanism of action of colchicine?

Anti-inflammatory action through microtubule disruption. ***Anti-inflammatory action through microtubule disruption*** - Colchicine works by binding to **tubulin**, thereby inhibiting its polymerization into microtubules. - This disruption of **microtubule formation** in neutrophils and other inflammatory cells prevents their migration and release of inflammatory mediators, thus exerting its anti-inflammatory effect [1].*Increase in uric acid excretion* - Medications that increase uric acid excretion are called **uricosurics**, such as **probenecid**. - Colchicine does not directly affect the renal excretion of uric acid [1].*Decrease in uric acid synthesis* - Medications that decrease uric acid synthesis, like **allopurinol** and **febuxostat**, inhibit the enzyme **xanthine oxidase**. - Colchicine does not inhibit xanthine oxidase and therefore does not reduce uric acid production.*None of the options* - This option is incorrect because **anti-inflammatory action through microtubule disruption** is a well-established mechanism of action for colchicine.

Q: Which of the following is a pure opioid antagonist?

Naloxone. ***Naloxone*** - **Naloxone** is a pure opioid antagonist that rapidly reverses the effects of opioid agonists by competing for opioid receptor binding sites [1,2]. - It has a high affinity for μ-opioid receptors and acts as a competitive antagonist [1], making it clinically useful for treating **opioid overdose**. *Buprenorphine* - **Buprenorphine** is a **partial opioid agonist** at the μ-opioid receptor and an antagonist at the κ-opioid receptor [4]. - It can precipitate withdrawal in opioid-dependent individuals if administered while full agonists are present due to its partial agonistic activity. *Pentazocine* - **Pentazocine** is a **mixed opioid agonist-antagonist**, acting as a partial agonist or antagonist at μ-opioid receptors and an agonist at κ-opioid receptors. - Its effects can vary, including analgesia (kappa agonism) and potential for withdrawal symptoms in opioid-dependent individuals (mu antagonism). *Morphine* - **Morphine** is a potent **full opioid agonist** that primarily acts on μ-opioid receptors, producing analgesia, sedation, and euphoria [3]. - It does not block opioid receptors; instead, it activates them, leading to its therapeutic and adverse effects.

Q: Which NSAID has been traditionally and most commonly used for the treatment of acute gout?

Indomethacin. ***Indomethacin*** - Historically, **indomethacin** has been the most frequently prescribed **NSAID** for acute **gouty arthritis** due to its potent anti-inflammatory properties. - It works by inhibiting prostaglandin synthesis, thereby reducing the **inflammation** and **pain** associated with acute gout attacks. - **Note:** While still effective, current guidelines recognize that any NSAID (including naproxen, diclofenac) can be equally effective; the choice depends on patient tolerability and comorbidities. *Aspirin* - **Aspirin** at low doses can actually **raise uric acid levels** by interfering with its renal secretion, potentially exacerbating or prolonging a gout attack. - Therefore, it is generally **contraindicated** for the treatment of acute gout. *Naproxen* - **Naproxen** is an effective NSAID for acute gout with better GI tolerability compared to indomethacin [1]. - Current guidelines consider it equivalent to indomethacin, but **historically**, indomethacin was the classic first-line choice for gout. *Diclofenac* - **Diclofenac** is an NSAID that can be effectively used for acute gout with efficacy similar to other NSAIDs. - While equally effective in current practice, it is not as **historically or classically** associated with gout treatment as **indomethacin**.

Question 1

Most important side effect of aspirin is?

Accepted Answer

Gastritis

Answer

Edema

Answer

Kidney damage

Answer

Hypersensitivity

Question 2

Which of the following is an opioid agonist-antagonist?

Accepted Answer

Pentazocine

Answer

Pethidine

Answer

Buprenorphine

Answer

Methadone

Question 3

Which drug has a ceiling effect?

Accepted Answer

Buprenorphine

Answer

Pethidine

Answer

Morphine

Answer

Fentanyl

Question 4

Belimumab is used in

Accepted Answer

Systemic lupus erythematosus

Answer

Osteoporosis

Answer

Malignant melanoma

Answer

Merkel cell carcinoma

Question 5

Azathioprine is used as a treatment for which specific condition?

Accepted Answer

Autoimmune diseases

Answer

Gout

Answer

HIV infection

Answer

Cancer

Question 6

Which among the following drugs produces a dose ceiling effect?

Accepted Answer

Buprenorphine (partial agonist)

Answer

Alfentanil (short-acting opioid)

Answer

Remifentanil (ultra-short-acting opioid)

Answer

Morphine (full agonist)

Question 7

Aspirin is used in chemoprevention of which cancer?

Accepted Answer

Colon cancer

Answer

Pancreatic cancer

Answer

Liver cancer

Answer

Stomach cancer

Question 8

Which among the following is a mechanism of action of colchicine?

Accepted Answer

Anti-inflammatory action through microtubule disruption

Answer

Decrease in uric acid synthesis

Answer

None of the options

Answer

Increase in uric acid excretion

Question 9

Which of the following is a pure opioid antagonist?

Accepted Answer

Naloxone

Answer

Buprenorphine

Answer

Pentazocine

Answer

Morphine

Question 10

Which NSAID has been traditionally and most commonly used for the treatment of acute gout?

Accepted Answer

Indomethacin

Answer

Aspirin

Answer

Naproxen

Answer

Diclofenac

Analgesics and Anti-inflammatory Drugs — MCQs

Analgesics and Anti-inflammatory Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?